Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-06

Clinical Trial Update: Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain [Phase 2]

View source ↗

Summary

Phase 2 mechanistic study of duloxetine in breast cancer patients with chronic pain has completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Pain | Phase 2 | Status: COMPLETED | Results posted: 2020-08-06